ALZC.F Stock Overview
AlzChem Group AG, together with its subsidiaries, develops, produces, and trades chemical products in Germany, European Union, rest of Europe, Asia, NAFTA region, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 2/6 |
| Past Performance | 6/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
AlzChem Group AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €49.00 |
| 52 Week High | €49.00 |
| 52 Week Low | €49.00 |
| Beta | 1.1 |
| 1 Month Change | n/a |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 77.28% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| ALZC.F | US Chemicals | US Market | |
|---|---|---|---|
| 7D | 0% | -0.2% | 2.0% |
| 1Y | n/a | 6.3% | 22.3% |
Return vs Industry: Insufficient data to determine how ALZC.F performed against the US Chemicals industry.
Return vs Market: Insufficient data to determine how ALZC.F performed against the US Market.
Price Volatility
| ALZC.F volatility | |
|---|---|
| ALZC.F Average Weekly Movement | n/a |
| Chemicals Industry Average Movement | 5.5% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: ALZC.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine ALZC.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1908 | 1,607 | Andreas Niedermaier | www.alzchem.com |
AlzChem Group AG, together with its subsidiaries, develops, produces, and trades chemical products in Germany, European Union, rest of Europe, Asia, NAFTA region, and internationally. It operates through three segments: Specialty Chemicals, Basics & Intermediates, and Other & Holding. The company offers dietary supplements under the Creapure and Alipure brands; preparation of guanidinoacetic acid as a nutritional feed additives under the Creamino brand; creatine dietary supplements under the LIVADUR brand; products for pharmaceuticals under the Bioselect brand; curing agents, including accelerators for use in adhesives, powder coatings, printed circuit boards, and composites under the DYHARD name; and silicon nitride for ceramics, and electronics and solar applications under the SILZOT brand.
AlzChem Group AG Fundamentals Summary
| ALZC.F fundamental statistics | |
|---|---|
| Market cap | US$498.58m |
| Earnings (TTM) | US$37.04m |
| Revenue (TTM) | US$583.85m |
13.5x
P/E Ratio0.9x
P/S RatioIs ALZC.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ALZC.F income statement (TTM) | |
|---|---|
| Revenue | €545.79m |
| Cost of Revenue | €241.72m |
| Gross Profit | €304.07m |
| Other Expenses | €269.45m |
| Earnings | €34.62m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Apr 30, 2024
| Earnings per share (EPS) | 3.40 |
| Gross Margin | 55.71% |
| Net Profit Margin | 6.34% |
| Debt/Equity Ratio | 35.2% |
How did ALZC.F perform over the long term?
See historical performance and comparison